Genomic Health, Inc. was awarded a firm fixed price blanket purchase agreement call by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 for $114,305 to provide Oncotype Genetic Testing Services from February 2024 through February 2028. The contract has no set-aside designation. Genomic Health will deliver its Oncotype DX portfolio of assays to support cancer screening, treatment selection, and disease monitoring programs at VA medical...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs Veterans Health Administration to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of proprietary genetic testing services for cancer diagnosis and treatment selection. The contract was issued as a Blanket Purchase Agreement (BPA) call order under Genomic Health's existing General Services Administration (GSA) Medical Laboratory Testing and Analysis Services schedule contract. The...
This is a definitive contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype testing services for cancer. The $325,998.94 firm fixed price contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 and does not have a set-aside designation. Genomic Health provides specialized genomic-based cancer diagnostic testing services, primarily focused on its Oncotype DX portfolio of tests that analyze gene expression...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, for their Oncotype DX cancer diagnostic services. The contract has a ceiling value of $3,453.96 and a period of performance through March 9, 2021. Genomic Health is a provider of genomic-based cancer testing services to federal agencies, including the VA, Department of Defense,...
This federal contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, is for the provision of the company's Oncotype DX portfolio of cancer diagnostic assays. The contract, valued at $200,327.28, was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA). It is a firm-fixed-price purchase order with a period of performance through September 30, 2025. The contract does not utilize a set-aside designation, as Genomic...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a $226,115.40 firm fixed price delivery order to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, for Genomic Oncotype breast, colon, and prostate cancer testing services. This order was placed under Genomic Health's existing Multiple Award Schedule contract for Medical Laboratory Testing and Analysis Services. Genomic Health has a history of providing cancer testing...
This is a firm fixed-price BPA call order awarded by the Department of Veterans Affairs (VA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, valued at $3,453.96, is for the provision of express cancer testing services, specifically Oncotype DX assays, to support the VA's healthcare programs. Genomic Health, as a provider of genomic-based cancer diagnostic tests, has received numerous prime and subcontractor awards from various federal agencies, including the...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, to provide reference lab testing services. The contract, valued at $228,525.24, was issued under the Medical Laboratory Testing and Analysis Services schedule and did not have a set-aside designation. Genomic Health has previously held multiple federal contracts with the Department of Defense and VA to deliver its...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded Genomic Health, Inc., a subsidiary of Exact Sciences Corp and Exact Sciences Laboratories, LLC doing business as Exact, a Blanket Purchase Agreement Call contract valued at nine hundred seventy thousand three hundred fifty-two United States dollars ($970,352) to provide Oncotype Genetic Testing Services. The contract has a period of performance starting on February 27, 2023...
This is a federal contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of the Oncotype portfolio of genomic tests to support patient care in anatomic pathology. The contract has a ceiling value of $145,066.32 and was awarded by the Defense Health Agency, a defense agency, on September 8, 2024. The contract type is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing structure, and an ultimate completion date of September 7,...